Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Exchange Rate Effect (2016 - 2025)

Avanos Medical's Exchange Rate Effect history spans 12 years, with the latest figure at -$4.2 million for Q4 2024.

  • For Q4 2024, Exchange Rate Effect fell 362.5% year-over-year to -$4.2 million; the TTM value through Dec 2024 reached -$4.1 million, down 2150.0%, while the annual FY2025 figure was $5.0 million, 221.95% up from the prior year.
  • Exchange Rate Effect for Q4 2024 was -$4.2 million at Avanos Medical, down from $1.8 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $3.8 million in Q4 2020 and bottomed at -$6.6 million in Q1 2020.
  • The 5-year median for Exchange Rate Effect is -$700000.0 (2023), against an average of -$421052.6.
  • The largest YoY upside for Exchange Rate Effect was 522.22% in 2022 against a maximum downside of 1050.0% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $3.8 million in 2020, then tumbled by 123.68% to -$900000.0 in 2021, then skyrocketed by 522.22% to $3.8 million in 2022, then plummeted by 57.89% to $1.6 million in 2023, then crashed by 362.5% to -$4.2 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Exchange Rate Effect are -$4.2 million (Q4 2024), $1.8 million (Q3 2024), and -$500000.0 (Q2 2024).